CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 57 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-13 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +112,500 | 150,000 | ||
| 2016-12-13 | Rouhandeh Steven H Executive Chairman | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2016-12-13 | Rouhandeh Steven H Executive Chairman | Grant or award · Stock option (right to buy) | +150,000 | 200,000 | ||
| 2016-11-08 | Ahn Mark J Director | Option exercise | +150,000 | $2.31 | $347K | 493,182 |
| 2016-11-08 | Ahn Mark J Director | Option exercise · Stock option (right to buy) | +150,000 | $2.31 | $347K | 0 |
| 2016-11-07 | Wider Todd Director | Grant or award | +100,000 | 100,000 | ||
| 2016-09-20 | Wider Todd Director | Purchase | +5,000 | $5.48 | $27K | 75,000 |
| 2016-02-11 | Howell Stephen B. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Rouhandeh Steven H Executive Chairman | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Rouhandeh Steven H Executive Chairman | Grant or award · Stock option (right to buy) | +150,000 | 200,000 | ||
| 2016-02-11 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +37,500 | 37,500 | ||
| 2016-02-11 | Jeffrey B Davis Chief Operating Officer | Grant or award · Stock option (right to buy) | +112,500 | 150,000 | ||
| 2016-02-11 | THOMPSON STEPHEN B VP-Finance Chief Acctg Officer | Grant or award · Stock option (right to buy) | +18,750 | 18,750 | ||
| 2016-02-11 | THOMPSON STEPHEN B VP-Finance Chief Acctg Officer | Grant or award · Stock option (right to buy) | +56,250 | 75,000 | ||
| 2016-02-11 | Wider Todd Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Alvino Mark Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Ahn Mark J Director | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2015-07-31 | Wider Todd Director | Purchase | +20,000 | $5.50 | $110K | 70,000 |
| 2015-07-31 | Ahn Mark J Director | Purchase | +18,182 | $5.50 | $100K | 343,182 |
| 2015-05-11 | Howell Stephen B. Director | Grant or award | +75,000 | 75,495 |
Page 21 of 23 · 443 trades